2016
DOI: 10.1016/j.vaccine.2016.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of public concerns about influenza vaccinations by mining a massive online question dataset in Japan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 29 publications
0
14
1
Order By: Relevance
“…By contrast, the participants who did not receive influenza vaccine had no particular reason on first of all reasons. The difference between previous studies and our results may elucidate that public concerns about influenza vaccination changed over time (Iwasa and Wada, 2013; Nawa et al, 2016; Hothersall et al, 2012). Among 20–64 year olds, having no experience of influenza, having economic reason and lacking time to visit hospital significantly differed between educational attainments.…”
Section: Discussioncontrasting
confidence: 99%
“…By contrast, the participants who did not receive influenza vaccine had no particular reason on first of all reasons. The difference between previous studies and our results may elucidate that public concerns about influenza vaccination changed over time (Iwasa and Wada, 2013; Nawa et al, 2016; Hothersall et al, 2012). Among 20–64 year olds, having no experience of influenza, having economic reason and lacking time to visit hospital significantly differed between educational attainments.…”
Section: Discussioncontrasting
confidence: 99%
“…published in three papers [36,38,39]; four studies were conducted in African countries: Guinea [40], Sierra Leone [37] or Guinea and Sierra Leone [41] (the degree of overlap between these two 2019 studies is unclear) and French Guiana [42]; and one in Japan [43]. Three studies (four papers) investigated participants with human T-cell lymphotropic virus type 1 (HTLV-1) [36,38,39,42]; three studies examined Ebola [37,40,41], and one explored influenza vaccination [43]. Four papers focused principally on women, mothers and pregnant women with HTLV-1 [36,38,39,42]; one study included a small number of men in its sample [38,39].…”
Section: Plos Onementioning
confidence: 99%
“…The three Ebola studies exclusively explored the views of health providers, managers, government officials, civil servants and staff from international agencies [37,40,41]. The study conducted in Japan did not specify the demographics of the sample [43]. The evidence base was at moderate risk of bias (see S1 Fig): the majority of studies presented a clear question, qualitative design, used appropriate methodology, and reported clear findings; however, only the three studies by Kodish and colleagues [37,40,41] clearly reported rigorous recruitment and data collection and analysis strategies; and only one study adequately addressed the relationships between researchers and participants (reflexivity) [37].…”
Section: Plos Onementioning
confidence: 99%
“…9 Both the quantity and quality of influenza vaccination related information may negatively/positively affect immunization programs. 10,11 During the influenza season of 2014-2015, in Italy, in the week from 12 th to 18 th November 2014, three deaths occurred shortly after the administration of Fluad, an inactivated trivalent influenza vaccine, adjuvanted with an oil-in-water emulsion adjuvant (squalene, sodium citrate dihydrate, citric acid monohydrate, polysorbate 80, sorbitan trioleate, MF59C.1), manufactured in Italy by Novartis (Novartis Vaccines and Diagnostics, Inc., NVD), first approved for use in Europe in 1997 and authorized in a number of European Union countries, including Austria, Belgium, Germany, Denmark, Greece, Spain, France, Ireland, Luxembourg, Portugal, and Sweden, as well as in Italy. The first case occurred in a 68-year-old subject who died of myocardial infarction several hours following vaccination.…”
Section: Introductionmentioning
confidence: 99%